Cargando…

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia

BACKGROUND: Advanced pancreatic ductal adenocarcinoma (PDAC) is characterized by progressive weight loss and nutritional deterioration. This wasting has been linked to poor survival outcomes, alterations in host defenses, decreased functional ability, and diminished health‐related quality of life (H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gresham, Gillian, Placencio‐Hickok, Veronica R., Lauzon, Marie, Nguyen, Tyra, Kim, Haesoo, Mehta, Sejal, Paski, Shirley, Pandol, Stephen J., Osipov, Arsen, Gong, Jun, Jamil, Laith H., Nissen, Nicholas, Lo, Simon K., Hendifar, Andrew E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718084/ https://www.ncbi.nlm.nih.gov/pubmed/34609081 http://dx.doi.org/10.1002/jcsm.12799

Ejemplares similares

Pancreatic cancer cachexia: a review of mechanisms and therapeutics
por: Tan, Carlyn R., et al.
Publicado: (2014)

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023)

Gut microbiome and pancreatic cancer cachexia: An evolving relationship
por: Hendifar, Andrew, et al.
Publicado: (2022)

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
por: Gong, Jun, et al.
Publicado: (2022)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
por: Gong, Jun, et al.
Publicado: (2019)

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2022)

A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
por: Anderson, Eric, et al.
Publicado: (2021)

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022)

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
por: Tuli, R., et al.
Publicado: (2019)

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma
por: Hendifar, Andrew, et al.
Publicado: (2016)

Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018
por: Samaan, Jamil S., et al.
Publicado: (2023)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
por: Guan, Michelle, et al.
Publicado: (2019)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
por: Anderson, Eric M., et al.
Publicado: (2021)

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
por: Murphy, R A, et al.
Publicado: (2011)

Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy
por: Kim, Sungjin, et al.
Publicado: (2020)

Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations
por: Lee, Patrick C., et al.
Publicado: (2021)

Chemotherapy-induced cachexia and model-informed dosing to preserve lean mass in cancer treatment
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2022)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

Su1077: PANCREATIC CANCER (PC) MORTALITY RATES ARE DECREASING IN YOUNG MEN BUT NOT YOUNG WOMEN IN THE US, 2000 – 2019: A POPULATION-BASED TIME-TREND ANALYSIS USING THE CDC'S NATIONAL CENTER OF HEALTH STATISTICS (NCHS) DATABASE
por: Abboud, Yazan, et al.
Publicado: (2022)

Autonomic Dysreflexia Resulting in Seizure After Colonoscopy in a Patient With Spinal Cord Injury
por: Fausel, Rebecca A., et al.
Publicado: (2014)

YouTube’s recommendation algorithm is left-leaning in the United States
por: Ibrahim, Hazem, et al.
Publicado: (2023)

Mapping the Segmental Microbiomes in the Human Small Bowel in Comparison with Stool: A REIMAGINE Study
por: Leite, Gabriela G. S., et al.
Publicado: (2020)

Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma
por: Lao, Yi, et al.
Publicado: (2019)

Ruptured, weighted, enteral feeding-tube tip presenting as enteric foreign objects
por: Meyer, Travis E., et al.
Publicado: (2015)

Circulating tumor DNA dynamics and response to immunotherapy in colorectal cancer
por: Gong, Jun, et al.
Publicado: (2022)

Enteral Tube Feeding in Paediatric Mitochondrial Diseases
por: Choi, Han Som, et al.
Publicado: (2017)

Pancreatic cancer ‘mismatch’ in Lynch syndrome
por: Hendifar, Andrew E, et al.
Publicado: (2019)

An incidental finding of endotracheal tube obstruction at the level where inflation line enters into the tube
por: Kumar, Arvind, et al.
Publicado: (2018)

The administration of lopinavir/ritonavir via an enteral feeding tube()
por: Sirvent Segovia, Alejandro Esteban, et al.
Publicado: (2021)

726 Enteral Tube Clogging and Medication Administration Techniques
por: Rathjen, Esther, et al.
Publicado: (2023)

Cancer cachexia.
por: Tisdale, M. J.
Publicado: (1991)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

Cancer cachexia
por: Dhanapal, Raghu, et al.
Publicado: (2011)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

Inflammation in Cachexia
por: Seelaender, M., et al.
Publicado: (2015)

Syphilitic Cachexia
por: Duckworth, Dyce
Publicado: (1908)

Splenic Cachexia
Publicado: (1904)

Cannot write session to /tmp/vufind_sessions/sess_1qt95j6cl37nkosqmuq86nrf8u